GI & Endoscopy

A study published in Science Translational Medicine examined gut microbiota composition in irritable bowel syndrome and inflammatory bowel disease patients.

Modernizing Medicine incorporated a suite of patient communication tools into its practice management software to reduce patient no-shows and improve compliance.

A study published in Gut examined whether annual fecal immunochemical testing could reduce reliance on surveillance colonoscopy.

A Colorado endoscopy clinic nurse pleaded guilty to stealing controlled substances from the center after having admitted to similar allegations with her previous employer, according to a Fox 21 report.

Here are three updates on gastroenterology companies from the past week:

Frank Friedenberg, MD, is the gastroenterology section chief at Philadelphia-based Temple University's Lewis Katz School of Medicine.

Chronic idiopathic constipation sufferers may soon find relief with the FDA approval of Shire's prucalopride.

Apollo Endosurgery sold its Lap-Band gastric banding device to ReShape Lifesciences for $17 million and acquired ReShape's intragastric balloon device, MassDevice reports.

Rita Ritsema, MD, will now see patients out of the Havertown, Pa.-based location of Bryn Mawr Medical Specialists Association, the Daily Times reports.

Motus GI Holdings will offer a follow-up to its initial public offering, including a proposed offering of 5,000,000 additional shares.